239 related articles for article (PubMed ID: 26758378)
1. Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups.
Boonvisut S; Nakayama K; Makishima S; Watanabe K; Miyashita H; Lkhagvasuren M; Kagawa Y; Iwamoto S
Lipids Health Dis; 2016 Jan; 15():8. PubMed ID: 26758378
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations.
Yan TT; Yin RX; Li Q; Huang P; Zeng XN; Huang KK; Aung LH; Wu DF; Liu CW; Pan SL
Lipids Health Dis; 2011 Dec; 10():248. PubMed ID: 22208664
[TBL] [Abstract][Full Text] [Related]
3. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control study.
Wu MJ; Yuan C; Lu LL; An BQ; Xuan SY; Xin YN
Lipids Health Dis; 2016 Nov; 15(1):207. PubMed ID: 27887608
[TBL] [Abstract][Full Text] [Related]
4. A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.
León-Mimila P; Vega-Badillo J; Gutiérrez-Vidal R; Villamil-Ramírez H; Villareal-Molina T; Larrieta-Carrasco E; López-Contreras BE; Kauffer LR; Maldonado-Pintado DG; Méndez-Sánchez N; Tovar AR; Hernández-Pando R; Velázquez-Cruz R; Campos-Pérez F; Aguilar-Salinas CA; Canizales-Quinteros S
Exp Mol Pathol; 2015 Apr; 98(2):178-83. PubMed ID: 25597287
[TBL] [Abstract][Full Text] [Related]
5. Association of the
Deng GX; Yin RX; Guan YZ; Liu CX; Zheng PF; Wei BL; Wu JZ; Miao L
Aging (Albany NY); 2020 Jun; 12(12):11893-11913. PubMed ID: 32568739
[TBL] [Abstract][Full Text] [Related]
6. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
Shang XR; Song JY; Liu FH; Ma J; Wang HJ
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
[TBL] [Abstract][Full Text] [Related]
7. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Liu YL; Reeves HL; Burt AD; Tiniakos D; McPherson S; Leathart JB; Allison ME; Alexander GJ; Piguet AC; Anty R; Donaldson P; Aithal GP; Francque S; Van Gaal L; Clement K; Ratziu V; Dufour JF; Day CP; Daly AK; Anstee QM
Nat Commun; 2014 Jun; 5():4309. PubMed ID: 24978903
[TBL] [Abstract][Full Text] [Related]
8. Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population.
Li Y; Liu S; Gao Y; Ma H; Zhan S; Yang Y; Xin Y; Xuan S
BMC Biochem; 2019 Feb; 20(1):3. PubMed ID: 30727943
[TBL] [Abstract][Full Text] [Related]
9. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.
Di Costanzo A; Belardinilli F; Bailetti D; Sponziello M; D'Erasmo L; Polimeni L; Baratta F; Pastori D; Ceci F; Montali A; Girelli G; De Masi B; Angeloni A; Giannini G; Del Ben M; Angelico F; Arca M
Sci Rep; 2018 Feb; 8(1):3702. PubMed ID: 29487372
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.
Gorden A; Yang R; Yerges-Armstrong LM; Ryan KA; Speliotes E; Borecki IB; Harris TB; Chu X; Wood GC; Still CD; Shuldiner AR; Gerhard GS;
Hum Hered; 2013; 75(1):34-43. PubMed ID: 23594525
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
Speliotes EK; Yerges-Armstrong LM; Wu J; Hernaez R; Kim LJ; Palmer CD; Gudnason V; Eiriksdottir G; Garcia ME; Launer LJ; Nalls MA; Clark JM; Mitchell BD; Shuldiner AR; Butler JL; Tomas M; Hoffmann U; Hwang SJ; Massaro JM; O'Donnell CJ; Sahani DV; Salomaa V; Schadt EE; Schwartz SM; Siscovick DS; ; ; ; Voight BF; Carr JJ; Feitosa MF; Harris TB; Fox CS; Smith AV; Kao WH; Hirschhorn JN; Borecki IB;
PLoS Genet; 2011 Mar; 7(3):e1001324. PubMed ID: 21423719
[TBL] [Abstract][Full Text] [Related]
13. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism in the FADS1/FADS2 gene is associated with plasma lipid profiles in two genetically similar Asian ethnic groups with distinctive differences in lifestyle.
Nakayama K; Bayasgalan T; Tazoe F; Yanagisawa Y; Gotoh T; Yamanaka K; Ogawa A; Munkhtulga L; Chimedregze U; Kagawa Y; Ishibashi S; Iwamoto S;
Hum Genet; 2010 Jun; 127(6):685-90. PubMed ID: 20364269
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis.
Cai W; Weng DH; Yan P; Lin YT; Dong ZH; Mailamuguli ; Yao H
Lipids Health Dis; 2019 Jan; 18(1):14. PubMed ID: 30646922
[TBL] [Abstract][Full Text] [Related]
16. The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects.
Chen X; Zhou P; De L; Li B; Su S
Mol Genet Genomic Med; 2019 Aug; 7(8):e824. PubMed ID: 31309745
[TBL] [Abstract][Full Text] [Related]
17. TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis.
Li XY; Liu Z; Li L; Wang HJ; Wang H
Front Endocrinol (Lausanne); 2022; 13():1026901. PubMed ID: 36353245
[TBL] [Abstract][Full Text] [Related]
18. Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.
Wruck W; Kashofer K; Rehman S; Daskalaki A; Berg D; Gralka E; Jozefczuk J; Drews K; Pandey V; Regenbrecht C; Wierling C; Turano P; Korf U; Zatloukal K; Lehrach H; Westerhoff HV; Adjaye J
Sci Data; 2015 Dec; 2():150068. PubMed ID: 26646939
[TBL] [Abstract][Full Text] [Related]
19. Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease.
Xue WY; Zhang L; Liu CM; Gao Y; Li SJ; Huai ZY; Dai J; Wang YY
Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):97-107. PubMed ID: 35057689
[TBL] [Abstract][Full Text] [Related]
20. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis.
Pirola CJ; Sookoian S
Hepatology; 2015 Dec; 62(6):1742-56. PubMed ID: 26331730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]